Search Results
263 items found for " fibrotic bone disease"
Posts (188)
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease The prevalence of non-alcoholic fatty liver disease (NAFLD) is Gaining control over disease-related events in non-alcoholic steatohepatitis (NASH), an advanced form
- FSH and bone: Comparison between males with central versus primary hypogonadism
The present study aims to investigate the possible role of FSH excess in male bone health, by comparing
- Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
., 2017 ), including those lining bone marrow (BM) sinusoids ( Duchene et al., 2017 ).
Other Pages (75)
- Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
but not fibrosis in a murine model with fibrotic bone Published date May 1, 2024 Abstract "G protein-coupled Fibrous dysplasia (FD) of the bone is characterized by fibrotic, expansile bone lesions caused by activating was hyper-activated in osteoblastic cell lineages using an engineered receptor strategy, developed a fibrotic Zamarioli, Apsara Ram, Gauri Ganesh, Misun Kang, Sunita Ho, Edward C Hsiao Tags Wnt pathway inhibition , fibrotic bone disease , fibrous dysplasia (FD) , osteoblasts , trabecular bone , G-protein coupled receptor signaling
- The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor
However, the physiological functions of many GPCRs and the involvement of them in autoimmune diseases almost no abnormalities in myeloid cell differentiation and compartmentalization in the spleen and bone However, Gpr141 deficiency exacerbated disease conditions of experimental autoimmune encephalomyelitis , an autoimmune disease model for multiple sclerosis, with increased inflammation in the spinal cord. that targeting GPR141 may be a possible therapeutic intervention for modulating chronic inflammatory diseases
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
Retreat Program < Back to schedule Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease